ID: ALA3979870

Max Phase: Preclinical

Molecular Formula: C38H37FN6O4S

Molecular Weight: 692.82

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1Cc2cc(ccc2S(=O)(=O)C2CC2)NC(=O)N(Cc2ccccc2)CCc2cccc(c2)[C@@H](Nc2ccc3c(N)ncc(F)c3c2)C1=O

Standard InChI:  InChI=1S/C38H37FN6O4S/c1-44-23-27-19-28(11-15-34(27)50(48,49)30-12-13-30)43-38(47)45(22-25-6-3-2-4-7-25)17-16-24-8-5-9-26(18-24)35(37(44)46)42-29-10-14-31-32(20-29)33(39)21-41-36(31)40/h2-11,14-15,18-21,30,35,42H,12-13,16-17,22-23H2,1H3,(H2,40,41)(H,43,47)/t35-/m1/s1

Standard InChI Key:  BKHFPLLGAGFDIZ-PGUFJCEWSA-N

Associated Targets(Human)

Coagulation factor VII/tissue factor 740 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 692.82Molecular Weight (Monoisotopic): 692.2581AlogP: 6.29#Rotatable Bonds: 6
Polar Surface Area: 137.73Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.36CX Basic pKa: 6.53CX LogP: 4.63CX LogD: 4.58
Aromatic Rings: 5Heavy Atoms: 50QED Weighted: 0.19Np Likeness Score: -0.45

References

1. Richter JM, Cheney DL, Bates JA, Wei A, Luettgen JM, Rendina AR, Harper TM, Narayanan R, Wong PC, Seiffert D, Wexler RR, Priestley ES..  (2017)  Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.,  (1): [PMID:28105277] [10.1021/acsmedchemlett.6b00375]

Source